Comorbidity patterns and socioeconomic inequalities in children under 15 with medical complexity: a population-based

Neus Carrilero1,2,3, Albert Dalmau-Bueno1, Anna García-Altés4,5,6

  • 1Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, Spain.

BMC Pediatrics
|August 1, 2020
PubMed

Insights

Children with medical complexity (CMC) often come from lower socioeconomic positions, with four distinct comorbidity patterns identified: oncology, neurodevelopment, congenital/perinatal, and respiratory. These findings highlight the need for tailored care addressing both medical and socioeconomic needs.

Area of Science:

  • Pediatrics
  • Public Health
  • Health Services Research

Background:

  • Children with medical complexity (CMC) have diverse health needs and high healthcare utilization.
  • Socioeconomic position (SEP) is a known factor affecting CMC.
  • Understanding comorbidity patterns and SEP inequalities is crucial for optimizing care.

Purpose of the Study:

  • To describe the pathologic patterns of CMC.
  • To analyze socioeconomic inequalities within these patterns.
  • To inform healthcare management and service planning for CMC.

Main Methods:

  • Cross-sectional study using administrative data from Catalonia (2016).
  • Latent Class Analysis (LCA) to identify multimorbidity classes in CMC.
  • Analysis of socioeconomic position (SEP) and Adjusted Morbidity Groups (GMA).

Main Results:

  • 71% of CMC had parents with low employment or income (<€18,000).
  • Four comorbidity classes identified: oncology (36.0%), neurodevelopment (13.7%), congenital/perinatal (19.8%), and respiratory (30.5%).
  • Significant associations found between SEP and all comorbidity classes, with higher odds for lower SEP children.

Conclusions:

  • Four distinct comorbidity patterns exist in CMC.
  • A high proportion of CMC children belong to lower socioeconomic groups across all patterns.
  • Results support tailored multidisciplinary teams and holistic care considering socioeconomic vulnerability.
Abstract

Related Concept Videos

Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
4.9K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.3K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
113
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
464
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
148